Navigation Links
Transcept Pharmaceuticals to Present at the 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
Date:1/29/2008
PT. RICHMOND, Calif., Jan. 29 /PRNewswire/ -- Transcept Pharmaceuticals, Inc. today announced that Glenn A. Oclassen, President & Chief Executive Officer, will present at the 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference at the Grand Hyatt Hotel in New York City on Tuesday, February 5, 2008 at 8:40 AM Eastern Time.
About Transcept Pharmaceuticals
Transcept Pharmaceuticals, Inc. is a specialty pharmaceutical company
deriving significant new patient benefits from proven CNS drugs. Transcept
development projects leverage new understanding of CNS conditions to
provide additional uses and enhanced clinical benefits for existing active
agents. The lead Transcept product, Intermezzo(R) (zolpidem tartrate
lozenge), is a low dose sublingual formulation of zolpidem for the
treatment of insomnia in patients who awaken in the middle of the night and
have difficulty returning to sleep. Phase 3 clinical trials have been
completed for Intermezzo(R) and Transcept plans to file an NDA in the third
quarter of 2008. Another product being developed by Transcept is TO-2060, a
novel, fixed-dose combination of olanzapine and ondansetron for the
treatment of dopamine associated psychiatric disorders. TO-2060 has
completed a successful dose ranging trial for the treatment of alcohol use
disorder and a full clinical development program has begun. For further
information, please visit the company's website at:
http://www.transcept.com.
Contacts:
Transcept Pharmaceuticals, Inc.
Michael Gill
Director of Communications
(510) 215-3575
The Ruth Group
Investors / Media
Stephanie Carrington / Jason Rando
(646) 536-7017 / 7025
| SOURCE Transcept Pharmaceuticals, Inc. Copyright©2008 PR Newswire. All rights reserved |
Related medicine news :
1. Transcept Pharmaceuticals to Present at RBC Capital Markets 2007 Healthcare Conference
2. Transcept Pharmaceuticals to Present at 19th Annual Piper Jaffray Health Care Conference
3. Transcept Pharmaceuticals, Inc. to Present at 2007 BIO Investor Forum
4. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
5. Amylin Pharmaceuticals Reports 2007 Financial Results
6. MiddleBrook Pharmaceuticals to Raise $21 Million Through Private Placement of Common Equity
7. Acura Pharmaceuticals, Inc. Announces Appointment of George K. Ross as Director
8. Wyeth and Teva Pharmaceuticals Extend the Standstill Period Relating to Tevas Launch of Generic Pantoprazole
9. Bradley Pharmaceuticals Announces Filing of Definitive Proxy Statement for Special Meeting of Stockholders to Approve Merger With Nycomed
10. MAP Pharmaceuticals Reaches Agreement with FDA on Special Protocol Assessment for MAP0004 Phase 3 Clinical Trial in Patients With Migraine
11. Access Licenses MuGard(TM) to RHEI Pharmaceuticals, a Leading Specialty Pharmaceutical Company for Distribution in China and Certain Other Southeast Asian Countries
Post Your Comments:
(Date:3/7/2014)... the centerpiece of a new theory regarding the ... painful disease affecting 1 in 10 women. , ... modification, a process that enhances or disrupts how ... the disease and its progression. Matthew Dyson, research ... University Feinberg School of Medicine and and Serdar ...
(Date:3/7/2014)... PLAINS, NY, March 7, 2014 -- Five researchers seeking ... goal of identifying women at risk of preterm labor ... awarded grant support from the March of Dimes. , ... seeking to understand what role genetic variations, infection, fetal ... triggering preterm labor. They have been awarded 2014 March ...
(Date:3/7/2014)... -- Seemingly healthy cells may in fact hide clues ... study led by researchers at The University of Texas ... in the Journal of the National Cancer Institute ... non-small cell lung cancer (NSCLC) showed the area adjacent ... researchers discovered the previously unknown role of a cancer-promoting ...
(Date:3/7/2014)... 7, 2014 -- A new study from St. ... declining, the rates of teenagers coming into Ontario ... 2006 and 2010. , Suicide-related behaviours are incidents ... from the Institute for Clinical Evaluative Sciences, the ... rates of teenagers coming into Ontario emergency departments ...
(Date:3/7/2014)... 2 diabetes have epigenetic changes on their DNA that ... in a major study by researchers at Lund University. ... number of genes that contribute to reduced insulin production., ... diabetes is not only genetic, but also epigenetic", said ... occur as a result of factors including environment and ...
Breaking Medicine News(10 mins):Health News:New theory on cause of endometriosis 2Health News:New research seeks to prevent preterm birth with March of Dimes support 2Health News:Cells appearing normal may actually be harbingers of lung cancer 2Health News:Cells appearing normal may actually be harbingers of lung cancer 3Health News:After years of improving, rates of youth suicide-related behaviors stopped declining 2Health News:Epigenetic changes could explain type 2 diabetes 2[0] New theory on cause of endometriosis[0] New research seeks to prevent preterm birth with March of Dimes support[0] Cells appearing normal may actually be harbingers of lung cancer[0] After years of improving, rates of youth suicide-related behaviors stopped declining[0] Epigenetic changes could explain type 2 diabetes
... supports the U.S. Senate in its introduction of the ... Radiation Therapy Act of 2010 (CARE Act), S. 3737. ... Sen. Mike Enzi [R-WY], aims to ensure that minimum ... set at the state level. The bill,s co-sponsors include ...
... Vitamin D may be an effective therapy to treat and ... severe complications for patients with cystic fibrosis and asthma, according ... University of Pittsburgh School of Medicine and Louisiana State University ... Kolls, M.D., Ph.D., a lung disease researcher at Children,s Hospital ...
... Gordon HealthDay Reporter , WEDNESDAY, Aug. 25 (HealthDay ... illnesses in America may share a connection, with new research ... your risk of developing the brain plaques associated with Alzheimer,s ... study found that people with the highest levels of fasting ...
... novel mechanism used by adenovirus to sidestep the cell,s suicide ... suppressor genes are silenced in tumor cells and pave the ... researchers at the Salk Institute for Biological Studies in the ... a cell is under stress, the tumor suppressor p53 springs ...
... (NYSE Amex:CUR) announced that it has filed an Investigational ... and Drug Administration (FDA) to begin a Phase I ... its spinal cord stem cells. This multicenter Phase I ... or chronic, spinal cord injury patients, with an American ...
... , WEDNESDAY, Aug. 25 (HealthDay News) -- U.S. scientists ... judge to halt any expansion of stem cell research ... blindsided the scientific community, effectively takes embryonic stem cell ... then-President George W. Bush ordered that federal monies could ...
Cached Medicine News:Health News:SNM applauds US Senate's introduction of CARE Act 2Health News:Vitamin D may treat and prevent allergic reaction to mold in cystic fibrosis patients 2Health News:Link Between Diabetes, Alzheimer's Disease Strengthened 2Health News:Link Between Diabetes, Alzheimer's Disease Strengthened 3Health News:Link Between Diabetes, Alzheimer's Disease Strengthened 4Health News:Use the common cold virus to target and disrupt cancer cells? 2Health News:Use the common cold virus to target and disrupt cancer cells? 3Health News:Neuralstem files FDA application for first chronic spinal cord injury stem cell trial 2Health News:Neuralstem files FDA application for first chronic spinal cord injury stem cell trial 3Health News:Obama to Appeal Stem Cell Ruling 2Health News:Obama to Appeal Stem Cell Ruling 3SNM applauds US Senate's introduction of CARE ActVitamin D may treat and prevent allergic reaction to mold in cystic fibrosis patientsLink Between Diabetes, Alzheimer's Disease StrengthenedUse the common cold virus to target and disrupt cancer cells?Neuralstem files FDA application for first chronic spinal cord injury stem cell trialObama to Appeal Stem Cell Ruling
(Date:1/15/2014)... 15, 2014 Reportlinker.com announces ... is available in its catalogue: ... Technologies for Advanced Drug Delivery Systems ... http://www.reportlinker.com/p01941928/Global-Markets-and-Technologies-for-Advanced-Drug-Delivery-Systems----Focus-on-Routes-of-Administration.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Delivery_Technology ... A drug delivery system is one ...
(Date:1/14/2014)... 2014 InformEx, North America,s ... of high-value chemistry, will hold the 30 th ... Miami Beach Convention Center from January 21-24. ... More than 3,500 attendees from top pharmaceutical, fine chemical ... conference, which includes on-site education sessions, daily networking events ...
(Date:1/14/2014)... Jan. 14, 2014 NuAire , a manufacturer of ... to agreement with Hitachi Koki of ... of centrifuges in North America . NuAire ... the United States and Canada ... features, options and accessories, training, pricing, as well as after ...
Breaking Medicine Technology:Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 2Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 4Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 6Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 7Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 8Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 9Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 10Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 11Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 12Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 13Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 14Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 15Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 16Media Advisory: InformEx 2014 Events & Speaker Lineup for 30th Edition Conference in Miami Beach 2NuAire announces sales and service of Hitachi Koki centrifuges in North America 2... Concentric Medical, Inc., the global leader in devices ... the launch of the expanded family of Merci Retrievers® ... Soft and V 3.0 Soft, through recent Ichihen Approval, ... now approved and reimbursed in Japan. The Merci Retriever® ...
... VIVUS, Inc. (NASDAQ: VVUS ) today ... breaking poster session at the 29th International Epilepsy Congress ... of Clinical Neurology, Department of Neurology, Columbia University Medical ... of medical claims data on oral clefts (OC) and ...
Cached Medicine Technology:Concentric Medical Launches Full Family of Merci Retrievers® in Japan 2Concentric Medical Launches Full Family of Merci Retrievers® in Japan 3Topiramate Exposure and Birth Defect Data to be Presented at the 29th International Epilepsy Congress 2Topiramate Exposure and Birth Defect Data to be Presented at the 29th International Epilepsy Congress 3Topiramate Exposure and Birth Defect Data to be Presented at the 29th International Epilepsy Congress 4Topiramate Exposure and Birth Defect Data to be Presented at the 29th International Epilepsy Congress 5... reloadable linear stapler with ... titanium staples., ,The ... staplers has application in ... thoracic surgical procedures for ...
... Single Use reloadable linear stapler for ... ,The Auto Suture™ MULTIFIRE GIA™ 60 ... MULTIFIRE GIA™ 60 and 80 single use ... SGIA™ 60 knifeless single use surgical stapler ...
... Single Use Loading Cartridges With Titanium Staples ... Stapler With Titanium Staples)., ,The PI™ ... the resection or transection of normal, healthy ... staggered row (or triple staggered row, when ...
... single-use stapler, anastomotic type, is designed ... and/or the anastomosis of normal, healthy ... 75 single-use stapler, anastomotic type, is ... transection, and/or the anastomosis of normal, ...
Medicine Products:| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |